This looks very promising. From mid-Oct to Dec 31 2009, NPHC made almost $600K in revenues from Cobroxin despite the fact that only a tiny part of the American public even knew about its existence, that its distribution was quite limited, and most of sold via internet alone.
If NPHC gets some solid TV commercials out there (which are coming) and stores get wind of the profit potential for a pain-reliever that works with none of the side effects of the usual suspects getting so much negative publicity in the last several months (which have to be cutting into consumer confidence and sales), I think that 2010 could be a banner year indeed for investors.
If I had more dry powder I know where I'd load it. But I'm happy with my "humble" chunk.
GLTA longs,
GreenMan